Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:PBE NYSEARCA:PJP NASDAQ:PSCH NYSEARCA:XHE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePBEInvesco Biotechnology & Genome ETF$66.70+2.3%$63.20$54.52▼$72.84$232.12M0.877,341 shs8,810 shsPJPInvesco Pharmaceuticals ETF$82.74+1.8%$80.36$72.25▼$89.87$239.95M0.668,730 shs2,970 shsPSCHInvesco S&P SmallCap Health Care ETF$40.80+2.0%$40.49$36.69▼$49.05$143.21M111,466 shs10,648 shsXHESPDR S&P Health Care Equipment ETF$81.65+0.7%$81.03$71.25▼$97.10$169.83M0.9415,423 shs6,545 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePBEInvesco Biotechnology & Genome ETF+1.02%+1.29%-0.21%+9.42%-0.31%PJPInvesco Pharmaceuticals ETF+1.01%+0.78%-0.33%+4.42%+0.69%PSCHInvesco S&P SmallCap Health Care ETF+1.76%-0.17%-3.17%-0.62%-5.64%XHESPDR S&P Health Care Equipment ETF+1.45%-0.67%-1.34%+4.36%-2.91%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPBEInvesco Biotechnology & Genome ETFN/AN/AN/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/APSCHInvesco S&P SmallCap Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/AXHESPDR S&P Health Care Equipment ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePBEInvesco Biotechnology & Genome ETF 2.71Moderate Buy$66.70N/APJPInvesco Pharmaceuticals ETF 2.67Moderate Buy$82.74N/APSCHInvesco S&P SmallCap Health Care ETF 2.76Moderate Buy$40.80N/AXHESPDR S&P Health Care Equipment ETF 2.68Moderate Buy$81.65N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPBEInvesco Biotechnology & Genome ETFN/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/AN/AN/AN/AN/APSCHInvesco S&P SmallCap Health Care ETFN/AN/AN/AN/AN/AN/AXHESPDR S&P Health Care Equipment ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePBEInvesco Biotechnology & Genome ETFN/AN/A18.88∞N/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/A16.14∞N/AN/AN/AN/AN/APSCHInvesco S&P SmallCap Health Care ETFN/AN/A22.16∞N/AN/AN/AN/AN/AXHESPDR S&P Health Care Equipment ETFN/AN/A29.20∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPBEInvesco Biotechnology & Genome ETF$0.160.24%N/AN/AN/APJPInvesco Pharmaceuticals ETF$0.961.16%N/AN/AN/APSCHInvesco S&P SmallCap Health Care ETF$0.030.07%N/AN/AN/AXHESPDR S&P Health Care Equipment ETF$0.050.06%N/AN/AN/ALatest PBE, PJP, XHE, and PSCH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/23/2025PSCHInvesco S&P SmallCap Health Care ETFQuarterly$0.00200.02%6/23/20256/23/20256/27/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPBEInvesco Biotechnology & Genome ETFN/APJPInvesco Pharmaceuticals ETFN/APSCHInvesco S&P SmallCap Health Care ETFN/AXHESPDR S&P Health Care Equipment ETFN/AInsider OwnershipCompanyInsider OwnershipPBEInvesco Biotechnology & Genome ETFN/APJPInvesco Pharmaceuticals ETFN/APSCHInvesco S&P SmallCap Health Care ETFN/AXHESPDR S&P Health Care Equipment ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePBEInvesco Biotechnology & Genome ETFN/A3.48 millionN/ANot OptionablePJPInvesco Pharmaceuticals ETFN/A2.90 millionN/ANot OptionablePSCHInvesco S&P SmallCap Health Care ETFN/A3.51 millionN/AOptionableXHESPDR S&P Health Care Equipment ETFN/A2.08 millionN/ANot OptionablePBE, PJP, XHE, and PSCH HeadlinesRecent News About These CompaniesIs SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?January 22, 2025 | zacks.comShould You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?January 2, 2025 | zacks.comSPDR S&P Health Care Equipment ETF declares quarterly distribution of $0.0252December 23, 2024 | msn.comWhen the Price of (XHE) Talks, People ListenNovember 26, 2024 | news.stocktradersdaily.comNIs SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?November 21, 2024 | zacks.comSPDR S&P U.S. Health Care Select Sector UCITS ETF (SXLV.L)November 16, 2024 | finance.yahoo.comHealthcare Investing Finding Growth Beyond PharmaceuticalsNovember 1, 2024 | seekingalpha.comShould You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?October 30, 2024 | zacks.comS&P 500 Health Care Equipment & Supplies Industry IndexOctober 17, 2024 | wsj.comHow to Take Advantage of moves in (XHE)October 14, 2024 | news.stocktradersdaily.comNWhen (XHE) Moves Investors should ListenOctober 4, 2024 | news.stocktradersdaily.comNBristol-Myers tops growth chart among S&P 500 healthcare stocks in Q3October 2, 2024 | seekingalpha.comSPDR Select Sector Fund - Health Care (ARCA:XLV), Short Interest ReportSeptember 28, 2024 | benzinga.com3 Semiconductor ETFs to Watch as Chip Demand RisesSeptember 23, 2024 | stocknews.comIs SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?September 19, 2024 | zacks.comShould You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?August 29, 2024 | zacks.com(XHE) Investment Analysis and AdviceAugust 28, 2024 | news.stocktradersdaily.comNSPDR S&P HEALTH CARE EQUIPMENT (^XHE-IV)July 20, 2024 | finance.yahoo.comIs SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?July 15, 2024 | zacks.comShould You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?June 24, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePBE, PJP, XHE, and PSCH Company DescriptionsInvesco Biotechnology & Genome ETF NYSEARCA:PBE$66.70 +1.51 (+2.32%) As of 04:10 PM EasternPowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.Invesco Pharmaceuticals ETF NYSEARCA:PJP$82.74 +1.44 (+1.77%) As of 04:10 PM EasternPowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.Invesco S&P SmallCap Health Care ETF NASDAQ:PSCH$40.80 +0.80 (+2.00%) As of 03:54 PM EasternPowerShares S&P SmallCap Health Care Portfolio (the Fund) seeks investment results that correspond generally to the price and yield performance of the index called the S&P SmallCap 600 Capped HealthCare Index (the Underlying Index). The Underlying Index consists of common stocks of the United States healthcare companies. These are companies that are principally engaged in the business of providing healthcare-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Fund seeks to normally invest at least 90% of its total assets in common stocks that comprise the Underlying Index. The Fund seeks to invest 25% or more of the value of its total assets in securities of issuers in an industry or group of industries to the extent that the Underlying Index concentrates in an industry or group of industries. The Fund's investment adviser is Invesco PowerShares Capital Management LLC.SPDR S&P Health Care Equipment ETF NYSEARCA:XHE$81.65 +0.55 (+0.68%) Closing price 04:10 PM EasternExtended Trading$81.60 -0.05 (-0.06%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The SPDR S&P Health Care Equipment ETF (XHE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equal-weighted index of U.S. health care equipment and supplies companies. XHE was launched on Jan 26, 2011 and is managed by State Street. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
